Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Raised by Global X Japan Co. Ltd.

Global X Japan Co. Ltd. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 46,289 shares of the medical equipment provider’s stock after acquiring an additional 4,140 shares during the quarter. Intuitive Surgical makes up approximately 3.0% of Global X Japan Co. Ltd.’s portfolio, making the stock its 12th largest holding. Global X Japan Co. Ltd.’s holdings in Intuitive Surgical were worth $24,161,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of ISRG. Beese Fulmer Investment Management Inc. grew its holdings in shares of Intuitive Surgical by 4.3% in the 4th quarter. Beese Fulmer Investment Management Inc. now owns 1,598 shares of the medical equipment provider’s stock valued at $834,000 after buying an additional 66 shares during the period. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in shares of Intuitive Surgical by 175.2% during the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 8,043 shares of the medical equipment provider’s stock worth $4,198,000 after purchasing an additional 5,120 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its stake in Intuitive Surgical by 5.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,523,863 shares of the medical equipment provider’s stock valued at $795,396,000 after buying an additional 73,225 shares during the period. Telligent Fund LP bought a new position in Intuitive Surgical in the 4th quarter valued at about $1,566,000. Finally, Strategic Financial Concepts LLC raised its stake in shares of Intuitive Surgical by 50,740.8% during the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after purchasing an additional 312,056 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,940 shares of company stock worth $3,333,485 over the last ninety days. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $588.50 on Friday. The company’s fifty day moving average is $553.03 and its two-hundred day moving average is $512.59. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $209.61 billion, a P/E ratio of 91.81, a PEG ratio of 5.51 and a beta of 1.39.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ISRG shares. Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.